U.S. Stock News

NasdaqGS:CNXC
NasdaqGS:CNXCProfessional Services

Concentrix (CNXC) Q4 EPS Collapse Challenges Bullish Margin Recovery Narratives

Concentrix (CNXC) closed out FY 2025 with Q4 revenue of US$2.6b and a basic EPS loss of US$23.83, alongside a net income loss of US$1.5b. On a trailing twelve month basis, revenue stood at US$9.8b with a net loss of US$1.3b and basic EPS of US$20.30. Over recent quarters the company has seen quarterly revenue move from US$2.4b in Q4 2024 to US$2.6b in Q4 2025. However, basic EPS shifted from US$1.73 and net income of US$111.0m in Q4 2024 to a sizable loss in the latest quarter, so the focus...
NasdaqGS:PCTY
NasdaqGS:PCTYProfessional Services

Is It Time To Reconsider Paylocity (PCTY) After A 24.7% One Year Share Price Drop

If you are wondering whether Paylocity Holding's share price around US$144.74 offers good value today, it helps to separate the story from the numbers and look at what the data actually says. Over the last week the stock has recorded a 5.1% decline, while the 1 year return sits at a 24.7% decline. This may prompt questions about whether expectations or perceived risk have shifted. Recent commentary around Paylocity has focused on its position in payroll and human capital management software,...
NasdaqGS:TIGR
NasdaqGS:TIGRCapital Markets

Is UP Fintech Holding (TIGR) Pricing In Its Recent 1 Year Rally And Current Valuation?

Wondering whether UP Fintech Holding offers genuine value at its current price, or if the recent excitement has already been priced in? This article breaks down what the numbers are saying about the stock. The share price sits at US$9.52 after a 7 day return of an 8.8% decline, a 30 day return of 3.0%, a year to date return of an 8.8% decline, a 1 year return of 54.5% and a 3 year return of 138.0%, while the 5 year return stands at a 36.2% decline. Recent coverage around UP Fintech Holding...
NasdaqCM:SSII
NasdaqCM:SSIIMedical Equipment

Surging 2025 Revenue and New Leadership Could Be A Game Changer For SS Innovations International (SSII)

SS Innovations International recently issued preliminary, unaudited results indicating fourth-quarter 2025 revenue of about US$15.0 million and full-year 2025 revenue of about US$43.0 million, both sharply higher than 2024 levels and driven by increased SSi Mantra surgical robot sales and installations. Alongside this growth, the company expanded its leadership bench by appointing veteran executive Milan Rao as both Chief Financial Officer and Global Chief Operating Officer, underscoring its...
NYSE:CIVI
NYSE:CIVIOil and Gas

Assessing Civitas Resources (CIVI) Valuation After Recent Share Price Weakness

Civitas Resources (CIVI) has drawn attention after a stretch of negative returns. The stock is down about 10% over the past month and 7% over the past 3 months, inviting closer scrutiny from investors. See our latest analysis for Civitas Resources. Those short term moves sit within a tougher stretch for holders, with a year to date share price return of a 5.11% decline and a 1 year total shareholder return of a 47.54% decline, even though the 5 year total shareholder return of a 72.84% gain...
NYSE:XHR
NYSE:XHRHotel and Resort REITs

Evaluating Xenia Hotels & Resorts (XHR) After Recent Share Price Momentum And Mixed Earnings Signals

Why Xenia Hotels & Resorts is on investors’ radar Xenia Hotels & Resorts (XHR) has been drawing attention after a period where the stock’s past 3 months return sits around 13%, alongside modest revenue growth and a weaker annual net income result. See our latest analysis for Xenia Hotels & Resorts. At a share price of US$14.75, Xenia Hotels & Resorts has seen a 12.94% 90 day share price return, while its 1 year total shareholder return of 4.92% and 5 year figure close to flat suggest momentum...
NYSE:RNR
NYSE:RNRInsurance

Is There Still Room In RenaissanceRe (RNR) After Strong Multi Year Share Price Gains?

If you are wondering whether RenaissanceRe Holdings is still good value at around US$270.10 per share, this breakdown is designed to help you make sense of the current price. The stock’s moves have been relatively muted recently, with a 0.7% decline over the last week, a 0.8% decline over the past month and year to date, and an 8.2% return over one year and 76.5% over five years. Recent attention on RenaissanceRe has centered on how the company is positioned within the insurance and...
NasdaqGS:TRST
NasdaqGS:TRSTBanks

Discovering US Undiscovered Gems in January 2026

As the U.S. market navigates through a period of fluctuating indices and economic indicators, small-cap stocks present unique opportunities amid broader market volatility. In this landscape, identifying promising companies requires a keen eye for innovation and resilience, particularly those that can thrive despite challenges such as inflationary pressures and shifting consumer trends.
NasdaqGS:LINE
NasdaqGS:LINEIndustrial REITs

The Bull Case For Lineage (LINE) Could Change Following Barclays Downgrade And Rising Analyst Caution

In the past week, Barclays analyst Brendan Lynch downgraded Lineage, Inc. from an “Overweight” to an “Equal-Weight” stance, reflecting a more cautious view of the company’s near-term prospects. This shift comes as several analysts have recently reduced their enthusiasm for Lineage, signaling a broader reassessment of the company’s outlook and risk profile. Next, we’ll examine how this growing analyst caution, particularly Barclays’ downgrade, may influence Lineage’s investment narrative...
NasdaqGS:ATEC
NasdaqGS:ATECMedical Equipment

A Look At Alphatec Holdings (ATEC) Valuation After 2026 Guidance Update And Theradaptive OsteoAdapt Deal

Alphatec Holdings (ATEC) grabbed attention after its 2026 revenue outlook implied slower growth at the same time the company secured exclusive U.S. rights to Theradaptive’s OsteoAdapt bone graft, sending the stock sharply lower. See our latest analysis for Alphatec Holdings. The guidance update and Theradaptive partnership arrived after a volatile stretch for the shares, with a 24.5% 7 day share price return decline and 17.6% 30 day share price return decline, even as the 1 year total...
OTCPK:SWRD
OTCPK:SWRDDiversified Financial

Assessing Stewards (OTCPK:SWRD) Valuation As Nasdaq Uplisting Plans Head To Sequire Investor Summit

Stewards at Sequire Investor Summit: Why This Event Matters Stewards (SWRD) is set to present at the Sequire Investor Summit 2026 in Puerto Rico, where management plans to outline its diversified operating platform and its progress toward a potential uplisting to the Nasdaq Capital Market. See our latest analysis for Stewards. The upcoming Sequire presentation comes after a choppy period for the stock, with a 1-day share price return of 5.26% contrasting with a 7-day decline of 15.25% and a...
NasdaqCM:NXXT
NasdaqCM:NXXTOil and Gas

Are NextNRG’s (NXXT) Healthcare Microgrid PPAs Quietly Redefining Its Infrastructure Risk Profile?

In early January 2026, NextNRG Inc. reported preliminary unaudited revenue of approximately US$8.01 million for 2025 and highlighted new healthcare microgrid power purchase agreements across assisted living and rehabilitation facilities, showcasing standardized, long-duration energy infrastructure capable of maintaining operations during grid disruptions while supporting regulatory compliance and predictable energy costs. Together, these contracts form a portfolio of long-term, contracted...
NasdaqGS:ROOT
NasdaqGS:ROOTInsurance

Assessing Root (ROOT) Valuation After Wells Fargo Turns More Cautious On Underwriting And Financial Health

Root (ROOT) is back in focus after a Wells Fargo analyst adopted a more cautious stance, pointing to concerns around the insurer’s financial position and a combined ratio of 102%, indicating underwriting losses. See our latest analysis for Root. The Wells Fargo call comes after a choppy stretch for Root, with a 1-day share price return of 6.71% decline taking the stock to US$74.26, a year to date share price return of 4.74%, and a 1-year total shareholder return of 12.44% decline. This...
NasdaqGM:EVER
NasdaqGM:EVERInteractive Media and Services

Assessing EverQuote (EVER) Valuation As Needham Growth Conference Presentation Draws Investor Attention

EverQuote (EVER) is scheduled to present at the 28th Annual Needham Growth Conference on January 13, 2026. The event has drawn fresh attention to the insurance marketplace stock. See our latest analysis for EverQuote. The upcoming Needham appearance comes after a mixed price pattern for EverQuote, with a 90 day share price return of 28.99% and a 1 year total shareholder return of 47.07%, although the 5 year total shareholder return stands at a 34% loss. At the latest share price of $26.34,...
NYSE:GKOS
NYSE:GKOSMedical Equipment

Is Glaukos (GKOS) Pricing Reflect Its Valuation After Recent Eye Care Focus?

If you are looking at Glaukos and wondering whether the current share price lines up with the underlying business, this article will walk through what the numbers actually say about value. The stock recently closed at US$110.23, with a 1.8% decline over the last week, a 1.2% gain over 30 days, a 0.4% decline year to date, a 25.5% decline over 1 year, and a 124.5% return over 3 years, alongside a 24.6% return over 5 years. Recent headlines around Glaukos have focused on its position in eye...
NasdaqGS:AEBI
NasdaqGS:AEBIMachinery

January 2026's Top Growth Stocks With Strong Insider Confidence

As of January 2026, the U.S. markets are reaching new heights, with the S&P 500 and Dow Jones Industrial Average closing at record highs despite concerns about a DOJ probe into Fed Chair Powell. This resilient performance highlights the importance of identifying growth companies with strong insider ownership, as such stocks often reflect confidence from those closest to the company's operations and can be particularly appealing in a thriving market environment.
NasdaqCM:ORMP
NasdaqCM:ORMPPharmaceuticals

3 Promising Penny Stocks With Market Caps Under $200M

As the S&P 500 and Dow Jones Industrial Average reach new highs, investors continue to navigate a landscape marked by both opportunities and challenges. For those looking to invest in smaller or newer companies, penny stocks — despite the name's vintage feel — can still offer surprising value. With solid financial foundations, these stocks have the potential to outperform while offering greater stability.